Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Gemin X
Both 1 hour and 3 hour infusions of obatoclax every 3 weeks will be evaluated in ascending doses.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologically or cytologically confirmed B-CLL
Previous standard systemic chemotherapy, including fludarabine. There are no limitations on additional, allowable type and amount of prior therapy. Acute toxicities from prior therapy must have resolved to ≤Grade 1
Age ≥18 years
ECOG Performance Status ≤1
Life expectancy of \>8 weeks
You may not be if
Patients receiving any other investigational agents (e.g., under another IND) or commercial agents or therapies administered with the intent to treat their malignancy
